Diagnostic Center | February 13, 2024
Lord's Mark Industries files patent for bio-chemistry reagents; Targets revenue of Rs. 200 Cr
These re-agent and diagnostic test kits come with 99.7% accuracy
These re-agent and diagnostic test kits come with 99.7% accuracy
Marks remarkable acceleration in innovation using AI technology
The super-resolution optical technology will accelerate discovery in biomedical research and transform in vitro diagnostics
The product will be produced at the Eugia Pharma Specialities, Unit-I, Medchal, Malkajgiri District, Telangana, India
Patent Term Extension is designed to restore some of the patent life lost during the regulatory review process for new drugs.
The application is in line with Innocan's strategy to expand the scope of its combined magnesium and cannabis topical solution
Agilent respectfully disagrees with the PTAB’s opinion of unpatentability in view of prior art previously considered by the USPTO during its primary examination
It provides doctors with three indicators: identification of the bone, confirmation of device insertion into the bone, and notification in case of perforation through the opposite end of the bone
Extends patent protection for Microbion's proprietary inhaled pravibismane for the treatment of pulmonary infections to 2039
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
Subscribe To Our Newsletter & Stay Updated
